Martinez, Jinky M.
HRN: 27-90-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/05/2025
CO-AMOXICLAV 625MG (TAB)
10/05/2025
10/12/2025
PO
625mg
BID
Lacerated Wound Forehead
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes